Nader Omidvar

1.3k total citations
18 papers, 946 citations indexed

About

Nader Omidvar is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Nader Omidvar has authored 18 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Hematology and 6 papers in Immunology. Recurrent topics in Nader Omidvar's work include Acute Myeloid Leukemia Research (9 papers), Immune Cell Function and Interaction (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Nader Omidvar is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Immune Cell Function and Interaction (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Nader Omidvar collaborates with scholars based in United Kingdom, United States and France. Nader Omidvar's co-authors include Richard Clarkson, Christine J. Watson, B. Paul Morgan, Wenjing Li, Blandine Kedjouar, James Turkson, Richard A. Flavell, Valeria Poli, Peter Kreuzaler and Anna D. Staniszewska and has published in prestigious journals such as Blood, The Journal of Immunology and Nature Cell Biology.

In The Last Decade

Nader Omidvar

18 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nader Omidvar United Kingdom 13 487 290 220 190 118 18 946
H. Elizabeth Broome United States 12 516 1.1× 385 1.3× 192 0.9× 121 0.6× 110 0.9× 29 1.1k
Boris Tchernychev United States 17 365 0.7× 270 0.9× 172 0.8× 253 1.3× 141 1.2× 24 1.0k
Raymond Yu United States 14 438 0.9× 312 1.1× 293 1.3× 72 0.4× 86 0.7× 22 919
Keiichi I. Nakayama Japan 14 745 1.5× 188 0.6× 336 1.5× 237 1.2× 145 1.2× 22 1.2k
Magali Herrant France 10 637 1.3× 179 0.6× 200 0.9× 180 0.9× 95 0.8× 11 883
H. Daniel Lacorazza United States 21 809 1.7× 559 1.9× 223 1.0× 227 1.2× 125 1.1× 61 1.5k
Muriel D. David France 20 851 1.7× 397 1.4× 283 1.3× 245 1.3× 197 1.7× 26 1.5k
Stuart A. Berger Canada 23 632 1.3× 340 1.2× 162 0.7× 126 0.7× 82 0.7× 42 1.1k
Hye‐Sook Kwon United States 12 423 0.9× 395 1.4× 198 0.9× 148 0.8× 66 0.6× 25 1.1k
Hee‐Jun Wee South Korea 22 887 1.8× 156 0.5× 354 1.6× 245 1.3× 197 1.7× 32 1.3k

Countries citing papers authored by Nader Omidvar

Since Specialization
Citations

This map shows the geographic impact of Nader Omidvar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nader Omidvar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nader Omidvar more than expected).

Fields of papers citing papers by Nader Omidvar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nader Omidvar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nader Omidvar. The network helps show where Nader Omidvar may publish in the future.

Co-authorship network of co-authors of Nader Omidvar

This figure shows the co-authorship network connecting the top 25 collaborators of Nader Omidvar. A scholar is included among the top collaborators of Nader Omidvar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nader Omidvar. Nader Omidvar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Protty, Majd, Nader Omidvar, Yugo Iwasaki, et al.. (2023). Phosphatidylthreonine is a procoagulant lipid detected in human blood and elevated in coronary artery disease. Journal of Lipid Research. 65(1). 100484–100484. 1 indexed citations
2.
3.
Robinson, Andrew, Namrata Rastogi, Michelle J. Doyle, et al.. (2019). Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leukemia via the Glycolytic Regulator PFKFB3. Cancer Research. 80(5). 937–949. 68 indexed citations
4.
Beurlet, Stéphanie, M.S. Said, Fabien Guidez, et al.. (2016). GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. Journal of Hematology & Oncology. 9(1). 5–5. 6 indexed citations
5.
Keeshan, Karen, Pauline Vieugué, Salma Chaudhury, et al.. (2016). Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBP  as a common target of TRIB1 and PML/RARA. Haematologica. 101(10). 1228–1236. 17 indexed citations
6.
Patel, Satyananda, Patricia Krief, Nader Omidvar, et al.. (2015). DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies. Oncotarget. 6(32). 32494–32508. 3 indexed citations
7.
Omidvar, Nader, Linda Jones, Bin Yin, et al.. (2012). PML-RAR  co-operates with Sox4 in acute myeloid leukemia development in mice. Haematologica. 98(3). 424–427. 12 indexed citations
8.
Kreuzaler, Peter, Anna D. Staniszewska, Wenjing Li, et al.. (2011). Stat3 controls lysosomal-mediated cell death in vivo. Nature Cell Biology. 13(3). 303–309. 246 indexed citations
9.
Omidvar, Nader, et al.. (2011). Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Cancer Research. 13(5). 96–96. 78 indexed citations
10.
Omidvar, Nader, et al.. (2008). A Dual Role for Oncostatin M Signaling in the Differentiation and Death of Mammary Epithelial Cells in Vivo. Molecular Endocrinology. 22(12). 2677–2688. 55 indexed citations
11.
Rassool, Feyruz V., Terry J. Gaymes, Nader Omidvar, et al.. (2007). Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia?. Cancer Research. 67(18). 8762–8771. 130 indexed citations
12.
Gaymes, Terry J., Rose Ann Padua, Marika Pla, et al.. (2006). Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis?. Molecular Cancer Research. 4(8). 563–573. 77 indexed citations
13.
Omidvar, Nader, Lorna Pearn, Alan K. Burnett, & Richard L. Darley. (2006). Ral Is both Necessary and Sufficient for the Inhibition of Myeloid Differentiation Mediated by Ras. Molecular and Cellular Biology. 26(10). 3966–3975. 14 indexed citations
14.
Omidvar, Nader, Eddie C. Y. Wang, Paul Brennan, et al.. (2006). Expression of Glycosylphosphatidylinositol-Anchored CD59 on Target Cells Enhances Human NK Cell-Mediated Cytotoxicity. The Journal of Immunology. 176(5). 2915–2923. 25 indexed citations
15.
Beek, Johan van, Marjan van Meurs, Bert A. ‘t Hart, et al.. (2005). Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation. The Journal of Immunology. 174(4). 2353–2365. 57 indexed citations
16.
Longhi, M. Paula, Baalasubramanian Sivasankar, Nader Omidvar, B. Paul Morgan, & Awen Gallimore. (2005). Cutting Edge: Murine CD59a Modulates Antiviral CD4+ T Cell Activity in a Complement-Independent Manner. The Journal of Immunology. 175(11). 7098–7102. 60 indexed citations
17.
Harris, Claire L., Rossen Donev, Masashi Mizuno, et al.. (2004). CD59a Is the Primary Regulator of Membrane Attack Complex Assembly in the Mouse. The Journal of Immunology. 173(6). 3684–3692. 68 indexed citations
18.
Darley, Richard L., Lorna Pearn, Nader Omidvar, et al.. (2002). Protein kinase C mediates mutant N-Ras–induced developmental abnormalities in normal human erythroid cells. Blood. 100(12). 4185–4192. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Elizabeth Broome Breakdown of academic impact, for papers by Boris Tchernychev Breakdown of academic impact, for papers by Raymond Yu Breakdown of academic impact, for papers by Keiichi I. Nakayama Breakdown of academic impact, for papers by Magali Herrant Breakdown of academic impact, for papers by H. Daniel Lacorazza Breakdown of academic impact, for papers by Muriel D. David Breakdown of academic impact, for papers by Stuart A. Berger Breakdown of academic impact, for papers by Hye‐Sook Kwon Breakdown of academic impact, for papers by Hee‐Jun Wee
Rankless by CCL
2026